Certainly, our findings indicate that SP100-AS1/miR-622/ATG3 axis contributes to radioresistance and autophagic flux in CRC, suggesting that it could be a potential target for improving CRC response to radiation therapy. The gene discussed is SP100; the disease is colorectal carcinoma.